Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Progenics Pharmaceuticals Inc

+ Add to Watchlist

PGNX:US

5.1900 USD 0.3100 5.64%

As of 20:10:00 ET on 05/26/2015.

Company Profile for Progenics Pharmaceuticals Inc (PGNX)

Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.

Contact Information

Progenics Pharmaceuticals Inc

777 Old Saw Mill River Road
Tarrytown, NY 10591
United States
Phone: 1-914-789-2800
Fax: 1-914-789-2817

Key Executives for Progenics Pharmaceuticals Inc (PGNX)

Mark Robert BakerChief Executive OfficerRobert J IsraelExec VP:Medical Affairs
Nitya G RaySenior VP:ManufacturingVivien WongSenior VP:Operations & Portfolio
Angelo W Lovallo JrVP:Finance/TreasurerAnn Marie AssummaVP:Regulatory Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil